Sökning: WFRF:(Sjoholm A) > Effects of intraven...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 01456naa a2200325 4500 | |
001 | oai:prod.swepub.kib.ki.se:124192541 | |
003 | SwePub | |
008 | 240701s2012 | |||||||||||000 ||eng| | |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1241925412 URI |
024 | 7 | a https://doi.org/10.1007/s00125-011-2440-x2 DOI |
040 | a (SwePub)ki | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Nathanson, Du Karolinska Institutet4 aut |
245 | 1 0 | a Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety |
264 | c 2012-01-13 | |
264 | 1 | b Springer Science and Business Media LLC,c 2012 |
700 | 1 | a Ullman, B4 aut |
700 | 1 | a Lofstrom, U4 aut |
700 | 1 | a Hedman, Au Karolinska Institutet4 aut |
700 | 1 | a Frick, Mu Karolinska Institutet4 aut |
700 | 1 | a Sjoholm, Au Karolinska Institutet4 aut |
700 | 1 | a Nystrom, Tu Karolinska Institutet4 aut |
710 | 2 | a Karolinska Institutet4 org |
773 | 0 | t Diabetologiad : Springer Science and Business Media LLCg 55:4, s. 926-935q 55:4<926-935x 1432-0428x 0012-186X |
856 | 4 | u https://link.springer.com/content/pdf/10.1007/s00125-011-2440-x.pdf |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:124192541 |
856 | 4 8 | u https://doi.org/10.1007/s00125-011-2440-x |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.